💊
Chenodeoxycholic acid Leadiant (previously Chenodeoxycholic acid sigma-tau)
chenodeoxycholic acid
Xanthomatose, cerebrotendinøs; stofskiftesygdomme, medfødte
✅ Autoriseret
✅
Ingen aktive alarmer
Denne medicin har ingen igangværende mangel, sikkerhedsbreve eller tilbagekaldelser.
Hvad det bruges til
Chenodeoxycholic acid is indicated for the treatment of inborn errors of primary bile acid synthesis due to sterol 27 hydroxylase deficiency (presenting as cerebrotendinous xanthomatosis (CTX)) in infants, children and adolescents aged 1 month to 18 years and adults.
⚠️ Patient sikkerhed
No